146 related articles for article (PubMed ID: 23598498)
1. A comparative chemical-biological evaluation of titanium(IV) complexes with a salan or cyclopentadienyl ligand.
Schur J; Manna CM; Deally A; Köster RW; Tacke M; Tshuva EY; Ott I
Chem Commun (Camb); 2013 May; 49(42):4785-7. PubMed ID: 23598498
[TBL] [Abstract][Full Text] [Related]
2. A marked synergistic effect in antitumor activity of salan titanium(IV) complexes bearing two differently substituted aromatic rings.
Glasner H; Tshuva EY
J Am Chem Soc; 2011 Oct; 133(42):16812-4. PubMed ID: 21967133
[TBL] [Abstract][Full Text] [Related]
3. Heteroleptic titanium(IV) catecholato/piperazine systems and their anti-cancer properties.
Hancock SL; Gati R; Mahon MF; Tshuva EY; Jones MD
Dalton Trans; 2014 Jan; 43(3):1380-5. PubMed ID: 24201896
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic dinuclear titanium-salan complexes: structural and biological characterization.
Immel TA; Grützke M; Batroff E; Groth U; Huhn T
J Inorg Biochem; 2012 Jan; 106(1):68-75. PubMed ID: 22112842
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic salan-titanium(IV) complexes: high activity toward a range of sensitive and drug-resistant cell lines, and mechanistic insights.
Manna CM; Braitbard O; Weiss E; Hochman J; Tshuva EY
ChemMedChem; 2012 Apr; 7(4):703-8. PubMed ID: 22262543
[TBL] [Abstract][Full Text] [Related]
6. High antitumor activity of highly resistant salan-titanium(IV) complexes in nanoparticles: an identified active species.
Meker S; Margulis-Goshen K; Weiss E; Magdassi S; Tshuva EY
Angew Chem Int Ed Engl; 2012 Oct; 51(42):10515-7. PubMed ID: 22961758
[TBL] [Abstract][Full Text] [Related]
7. First polymer "ruthenium-cyclopentadienyl" complex as potential anticancer agent.
Valente A; Garcia MH; Marques F; Miao Y; Rousseau C; Zinck P
J Inorg Biochem; 2013 Oct; 127():79-81. PubMed ID: 23896008
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic titanium salan complexes: surprising interaction of salan and alkoxy ligands.
Immel TA; Groth U; Huhn T
Chemistry; 2010 Mar; 16(9):2775-89. PubMed ID: 20104550
[TBL] [Abstract][Full Text] [Related]
9. Different ortho and para electronic effects on hydrolysis and cytotoxicity of diamino bis(phenolato) "salan" Ti(IV) complexes.
Peri D; Meker S; Manna CM; Tshuva EY
Inorg Chem; 2011 Feb; 50(3):1030-8. PubMed ID: 21214265
[TBL] [Abstract][Full Text] [Related]
10. Major impact of N-methylation on cytotoxicity and hydrolysis of salan Ti(IV) complexes: sterics and electronics are intertwined.
Meker S; Manna CM; Peri D; Tshuva EY
Dalton Trans; 2011 Oct; 40(38):9802-9. PubMed ID: 21874187
[TBL] [Abstract][Full Text] [Related]
11. Unexpected influence of stereochemistry on the cytotoxicity of highly efficient Ti(IV) salan complexes: new mechanistic insights.
Manna CM; Armony G; Tshuva EY
Chemistry; 2011 Dec; 17(50):14094-103. PubMed ID: 22076809
[TBL] [Abstract][Full Text] [Related]
12. Trans titanium(IV) complexes of salen ligands exhibit high antitumor activity.
Tzubery A; Tshuva EY
Inorg Chem; 2011 Sep; 50(17):7946-8. PubMed ID: 21797239
[TBL] [Abstract][Full Text] [Related]
13. Differential cytotoxicity induced by the Titanium(IV)Salan complex Tc52 in G2-phase independent of DNA damage.
Pesch T; Schuhwerk H; Wyrsch P; Immel T; Dirks W; Bürkle A; Huhn T; Beneke S
BMC Cancer; 2016 Jul; 16():469. PubMed ID: 27412346
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
15. New insights on the active species and mechanism of cytotoxicity of salan-Ti(IV) complexes: a stereochemical study.
Manna CM; Armony G; Tshuva EY
Inorg Chem; 2011 Oct; 50(20):10284-91. PubMed ID: 21923127
[TBL] [Abstract][Full Text] [Related]
16. From catalysts to bioactive organometallics: do Grubbs catalysts trigger biological effects?
Oehninger L; Alborzinia H; Ludewig S; Baumann K; Wölfl S; Ott I
ChemMedChem; 2011 Dec; 6(12):2142-5. PubMed ID: 21901835
[No Abstract] [Full Text] [Related]
17. Anti-proliferative activity of nano-formulated phenolato titanium(IV) complexes against cancer cells.
Meker S; Margulis-Goshen K; Weiss E; Braitbard O; Hochman J; Magdassi S; Tshuva EY
ChemMedChem; 2014 Jun; 9(6):1294-8. PubMed ID: 24677761
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumoral Titanium
Zhao T; Wang P; Zhang X; Liu N; Zhao W; Zhang Y; Yuan P; Li S; Yang M; Yang Z; Huhn T
Curr Top Med Chem; 2023; 23(19):1835-1849. PubMed ID: 37151173
[TBL] [Abstract][Full Text] [Related]
19. Active cytotoxic reagents based on non-metallocene non-diketonato well-defined C2-symmetrical titanium complexes of tetradentate bis(phenolato) ligands.
Shavit M; Peri D; Manna CM; Alexander JS; Tshuva EY
J Am Chem Soc; 2007 Oct; 129(40):12098-9. PubMed ID: 17877357
[No Abstract] [Full Text] [Related]
20. Highly cytotoxic vanadium(V) complexes of salan ligands; insights on the role of hydrolysis.
Reytman L; Braitbard O; Tshuva EY
Dalton Trans; 2012 May; 41(17):5241-7. PubMed ID: 22415291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]